Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: Recommendations from a European nursing task group

✍ Scribed by Kim Edmonds; Diana Hull; Andrea Spencer-Shaw; José Koldenhof; Maria Chrysou; Christine Boers-Doets; Alexander Molassiotis

• Book ID: 116436994
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 520 KB
• Volume: 16
• Category: Article
• ISSN: 1462-3889
• DOI: 10.1016/j.ejon.2011.05.001